| NIH Pharmacogenomics Grants, September — October 2006 | |||
|  
       Organization 
        Name 
     | 
     
       Award  | 
     
       Principal 
        Investigator 
     | 
     
       Title 
     | 
  
| University of Texas MD Anderson Cancer Center |  
        $273,350 
     | 
    Abruzzo, Lynne | Validation of RNA and DNA Biomarkers of Prognosis in Chronic Lymphocytic Leukemia | 
| Columbia University Health Sciences |  
       $2,180,106 
     | 
    Ahsan, Habibul | Genomewide association in early-onset breast cancer | 
| Source Precision Medicine |  
        NA 
     | 
    Bankaitis-Davis, Danute | Early Prediction of Therapy Responders in Chronic HCV | 
| Johns Hopkins University |  
        $781,539 
     | 
    Baylin, Stephen | Cancer Genome Characterization Center at Johns Hopkins | 
| Stanford University |  
       $391,250 
     | 
    Butte, Atul | Enabling new discoveries in pharmacogenomics through a genomic date-driven nosolology | 
| Cleveland Clinic |  
       $1,955,979 
     | 
    Casey, Graham | Genomic Wide Association Study of Colorectal Cancer | 
| University of Pennsylvania |  
       NA 
     | 
    Fitzgerald, Garret | Clinical Aspects of Aspirin and Clopidogrel Resistance | 
| Fred Hutchinson Cancer Research Center |  
       $796,807 
     | 
    Gentleman, Robert | Bioconductor: an open computing resource for genomics | 
| University of Alabama at Birmingham |  
       $200,000 
     | 
    Guay-Woodford, Lisa | Genetics and Pharmacogenetics in FSGS (PPG Project 4) | 
| University of California, Los Angeles |  
       $270,375 
     | 
    Hankinson, Oliver | Function and Regulation of Human Cytochrome P4502S1 | 
| University of Texas Health Science Center |  
       $315,023 
     | 
    Hecht, Jacqueline | Genetic Studies of Clubfoot (ITEV) | 
| Kovogen |  
       $130,147 
     | 
    Kovoor, Abraham | A Genetic Test for Drug-Induced Dyskinesia Risk | 
| New York University |  
       $26,784 
     | 
    Listman, Jennifer | Population Genetics & Drug Dependence in Asian Isolates | 
| Massachusetts Institute of Technology |  
       $2,387,778 
     | 
    Meyerson, Matthew | Center for Cancer Genome Characterization | 
| University of Arkansas |  
       $450,491 
     | 
    Nowell, Susan | Pharmacogenetics of Hormonal Therapy for Breast Cancer | 
| University of Kansas Medical Center |  
       $189,750 
     | 
    Reed, Gregory | Probe Drugs for Botanical-Drug Interactions | 
| Columbia University Health Sciences |  
       $87,582 
     | 
    Shen, Jing | Telomere dysfunction, oxidative damage and breast cancer risk | 
| DeCode Genetics |  
       $470,486 
     | 
    Stefansson, Kari | Genes Contributing to Opioid Abuse in Humans | 
| Cold Spring Harbor Laboratory |  
        $418,750 
     | 
    Stein, Lincoln | Enhancing the HapMap Web Site | 
| Cleveland Clinic |  
       NA 
     | 
    Topol, Eric | Molecular Basis of Resistance to Anti-Platelet Agents | 
|  
       *SOURCE: 
        US National Institutes of Health 
     | 
  |||